Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Rebbeck

Showing results (41-50 of 416) with videos related to

Pageof 42
Sort By:
JAMA Network Open|October 17, 2025
Geographic and Temporal Patterns of Screening for Breast, Cervical, and Colorectal Cancer in the US, 1997-2019Pranoti Pradhan, Hari S Iyer, Timothy R Rebbeck
Journal of the National Comprehensive Cancer Network : JNCCN|February 3, 2006
Bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriersSusan M Domchek, Jill E Stopfer, Timothy R Rebbeck
Infectious Agents and Cancer|December 17, 2016
African Organization for Research and Training in Cancer: position and vision for cancer research on the African ContinentJ Olufemi Ogunbiyi, D Cristina Stefan, Timothy R Rebbeck
Journal of the National Cancer Institute|January 15, 2009
Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriersTimothy R Rebbeck, Noah D Kauff, Susan M Domchek
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 2, 2012
Cancer prevention for global health: a report from the ASPO International Cancer Prevention Interest GroupDejana Braithwaite, Paolo Boffetta, Timothy R Rebbeck, et al.
Journal of Oncology|January 30, 2010
Germline mutations and polymorphisms in the origins of cancers in womenKim M Hirshfield, Timothy R Rebbeck, Arnold J Levine
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2009
Null results in brief: meeting a need in changing timesPeter G Shields, Thomas A Sellers, Timothy R Rebbeck
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
Genetic association studies of cancer: where do we go from here?Timothy R Rebbeck, Muin J Khoury, John D Potter
Journal of the National Cancer Institute|May 15, 2014
Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysisTara M Friebel, Susan M Domchek, Timothy R Rebbeck
NPJ Precision Oncology|June 17, 2022
The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancerKevin H Kensler, Shakuntala Baichoo, Shailja Pathania, et al.
Pageof 42

Showing results (41-50 of 416) with videos related to

Sort By:
Pageof 42
JAMA Network Open|October 17, 2025
Geographic and Temporal Patterns of Screening for Breast, Cervical, and Colorectal Cancer in the US, 1997-2019Pranoti Pradhan, Hari S Iyer, Timothy R Rebbeck
Journal of the National Comprehensive Cancer Network : JNCCN|February 3, 2006
Bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriersSusan M Domchek, Jill E Stopfer, Timothy R Rebbeck
Infectious Agents and Cancer|December 17, 2016
African Organization for Research and Training in Cancer: position and vision for cancer research on the African ContinentJ Olufemi Ogunbiyi, D Cristina Stefan, Timothy R Rebbeck
Journal of the National Cancer Institute|January 15, 2009
Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriersTimothy R Rebbeck, Noah D Kauff, Susan M Domchek
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 2, 2012
Cancer prevention for global health: a report from the ASPO International Cancer Prevention Interest GroupDejana Braithwaite, Paolo Boffetta, Timothy R Rebbeck, et al.
Journal of Oncology|January 30, 2010
Germline mutations and polymorphisms in the origins of cancers in womenKim M Hirshfield, Timothy R Rebbeck, Arnold J Levine
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2009
Null results in brief: meeting a need in changing timesPeter G Shields, Thomas A Sellers, Timothy R Rebbeck
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
Genetic association studies of cancer: where do we go from here?Timothy R Rebbeck, Muin J Khoury, John D Potter
Journal of the National Cancer Institute|May 15, 2014
Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysisTara M Friebel, Susan M Domchek, Timothy R Rebbeck
NPJ Precision Oncology|June 17, 2022
The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancerKevin H Kensler, Shakuntala Baichoo, Shailja Pathania, et al.
Pageof 42